for a share that is so leveraged to market returns it did well today to be down only 1c or 0.7%.Obviously value from future Countplus is stabilising
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025